Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study
about
sameAs
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?Illicit use of androgens and other hormones: recent advancesAdverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implicationsIllicit anabolic-androgenic steroid useThe diagnostic dilemma of pathological appearance and performance enhancing drug useProlonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control StudyGonadotropins in doping: pharmacological basis and detection of illicit use.Modulatory effect of gonadotropins on rats' ovaries after nandrolone decanoate administration: a stereological study.Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.The Impact of Intense Exercise on Semen Quality.Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids.Impaired Physical Performance and Clinical Responses after a Recreational Bodybuilder's Self-Administration of Steroids: A Case Report
P2860
Q24649521-6400AD34-44AF-434E-B923-2912C249F20CQ26824840-776FF052-039E-4792-B4E1-9AB4D3990443Q30409171-FF499B0E-C991-4BC7-97C2-BA9D38C46677Q33872639-27111A5E-65BE-48FD-8660-08E4A320000AQ33905686-A2FB03D9-A694-4C26-9113-E9D3A4494273Q34574338-718AFD8B-9D38-4B3E-9D09-3D5B483D231EQ35434335-83E029D2-54FE-485E-A9E2-1AA954FCA91EQ36105715-553A4D7F-C61E-41F9-A6E7-F25546155F52Q36736090-494EFEF1-71F0-41F3-8633-4474F684DBD0Q37494090-484F9544-BB3F-434F-A418-6DCE37FF48B3Q38261724-716A9225-EA71-4372-939B-AEAFC1CCAA38Q38958905-1F117E97-D454-4FA8-B30A-A357DB49D374Q40006341-7245CBF3-39CF-4B8D-AEBD-47C156735825Q42162610-139BA00D-28D7-4A67-9703-AAE63F03A328
P2860
Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@ast
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@en
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@nl
type
label
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@ast
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@en
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@nl
prefLabel
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@ast
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@en
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@nl
P3181
P356
P1476
Androgenic anabolic steroid us ...... tary dysfunction: a case study
@en
P2093
P304
P3181
P356
10.1055/S-2003-39089
P407
P577
2003-04-01T00:00:00Z